Century Therapeutics (IPSC)SVP Finance & Operations sold ~$544

~$544

Approx. value · 275 sh @ $1.98

505K

Holds after · shares reported

Traded

Aug 3, 2026

Filed

Aug 5, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jun 8, 2026Insider · 2 peopleInsiders: 2 sales (~$2K)
2. Jun 11, 2026Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote
3. Jun 12, 2026Insider · 2 peopleInsiders: 2 sales (~$9K)
4. Jun 15, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member
5. Aug 3, 2026 · this disclosureInsiderOfficer sold ~$544 of IPSC shares in the open market

What came next

1. Aug 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
2. Sep 8, 2026Insider · 2 peopleInsiders: 2 sales (~$2K)
3. Sep 9, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 9, 2026, the Board of Directors (the “Board”) of Century Therapeutics, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased its size from six to seven directors and appointed Mr. Joseph Truitt as a member of the Board, effective as of September 9, 2026 (the “Effective Date”).”
4. Sep 14, 2026Insider · 2 peopleInsiders: 2 sales (~$8K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Century Therapeutics

For Century Therapeutics, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IPSC page.

Other recent filings by Douglas Carr, SVP Finance & Operations

• SEC Form 4 at Century Therapeutics (IPSC)Sep 15, 2026
• SEC Form 4 at Century Therapeutics (IPSC)Sep 9, 2026
• SEC Form 4 at Century Therapeutics (IPSC)Jun 15, 2026
• SEC Form 4 at Century Therapeutics (IPSC)Jun 9, 2026
• SEC Form 4 at Century Therapeutics (IPSC)May 6, 2026

The full history of Douglas Carr, SVP Finance & Operations is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Century Therapeutics

• SEC Form 4Sep 15, 2026
• SEC Form 4Sep 15, 2026
• SEC Form 4Sep 9, 2026
• SEC Form 4Sep 9, 2026
• SEC Form 4Jun 15, 2026
• SEC Form 4Jun 15, 2026

Everything OQRO holds on this company is on its IPSC page.